$CASI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CASI Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CASI Pharmaceuticals, Inc.. Get notifications about new insider transactions in CASI Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2006 | CASI | CASI Pharmaceutica ... | CAPE RONALD | Director | Grant | A | 0.00 | 16,025 | 0 | 40,216 | 24.2 K to 40.2 K (+66.24 %) |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | RANDALL MARK C M | Director | Option Exercise | A | 1.56 | 35,000 | 54,600 | 35,000 | |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | RANDALL MARK C M | Director | Grant | A | 0.00 | 16,025 | 0 | 40,216 | 24.2 K to 40.2 K (+66.24 %) |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Option Exercise | A | 1.56 | 30,000 | 46,800 | 30,000 | |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.00 | 16,025 | 0 | 35,663 | 19.6 K to 35.7 K (+81.60 %) |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | BROOKS DONALD S | Director | Option Exercise | A | 1.56 | 30,000 | 46,800 | 30,000 | |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | BROOKS DONALD S | Director | Grant | A | 0.00 | 16,025 | 0 | 40,216 | 24.2 K to 40.2 K (+66.24 %) |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | KNIGHT PETER S | Director | Option Exercise | A | 1.56 | 35,000 | 54,600 | 35,000 | |
Jun 19 2006 | CASI | CASI Pharmaceutica ... | KNIGHT PETER S | Director | Grant | A | 0.00 | 16,025 | 0 | 40,216 | 24.2 K to 40.2 K (+66.24 %) |
Jun 14 2006 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.58 | 5,000 | 7,900 | 70,000 | 65 K to 70 K (+7.69 %) |
Jun 02 2006 | CASI | CASI Pharmaceutica ... | Wong Cynthia | VP,General Counsel, ... | Option Exercise | A | 1.76 | 100,000 | 176,000 | 100,000 | |
Dec 28 2005 | CASI | CASI Pharmaceutica ... | Sidor Carolyn F | Corp. VP & Chief Me ... | Option Exercise | A | 1.94 | 40,000 | 77,600 | 40,000 | |
Dec 28 2005 | CASI | CASI Pharmaceutica ... | SAGLIO DANE R | Chief Financial Off ... | Option Exercise | A | 1.94 | 40,000 | 77,600 | 40,000 | |
Dec 28 2005 | CASI | CASI Pharmaceutica ... | Corrado Marc | VP Corporate Develo ... | Option Exercise | A | 1.94 | 30,000 | 58,200 | 30,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | BUSH DWIGHT L | Director | Option Exercise | A | 3.10 | 35,000 | 108,500 | 35,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | BUSH DWIGHT L | Director | Grant | A | 0.00 | 8,064 | 0 | 24,191 | 16.1 K to 24.2 K (+50.00 %) |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Option Exercise | A | 3.10 | 30,000 | 93,000 | 30,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 0.00 | 8,064 | 0 | 24,191 | 16.1 K to 24.2 K (+50.00 %) |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | HUNTER CEVERA JENNIE | Director | Option Exercise | A | 3.10 | 30,000 | 93,000 | 30,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | HUNTER CEVERA JENNIE | Director | Grant | A | 0.00 | 8,064 | 0 | 24,191 | 16.1 K to 24.2 K (+50.00 %) |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | CAPE RONALD | Director | Option Exercise | A | 3.10 | 30,000 | 93,000 | 30,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | CAPE RONALD | Director | Grant | A | 0.00 | 8,064 | 0 | 24,191 | 16.1 K to 24.2 K (+50.00 %) |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | RANDALL MARK C M | Director | Option Exercise | A | 3.10 | 35,000 | 108,500 | 35,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | RANDALL MARK C M | Director | Grant | A | 0.00 | 8,064 | 0 | 24,191 | 16.1 K to 24.2 K (+50.00 %) |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | BROOKS DONALD S | Director | Option Exercise | A | 3.10 | 30,000 | 93,000 | 30,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | BROOKS DONALD S | Director | Grant | A | 0.00 | 8,064 | 0 | 24,191 | 16.1 K to 24.2 K (+50.00 %) |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | KNIGHT PETER S | Director | Option Exercise | A | 3.10 | 35,000 | 108,500 | 35,000 | |
Jul 29 2005 | CASI | CASI Pharmaceutica ... | KNIGHT PETER S | Director | Grant | A | 0.00 | 8,064 | 0 | 24,191 | 16.1 K to 24.2 K (+50.00 %) |
Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.37 | 7,500 | 17,775 | 65,000 | 57.5 K to 65 K (+13.04 %) |
Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.36 | 3,900 | 9,204 | 57,500 | 53.6 K to 57.5 K (+7.28 %) |
Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.39 | 400 | 956 | 53,600 | 53.2 K to 53.6 K (+0.75 %) |
Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.40 | 2,800 | 6,720 | 53,200 | 50.4 K to 53.2 K (+5.56 %) |
Apr 07 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.35 | 400 | 940 | 50,400 | 50 K to 50.4 K (+0.80 %) |
Apr 01 2005 | CASI | CASI Pharmaceutica ... | CELGENE CORP /DE/ | 10% Owner | Option Exercise | X | 1.50 | 7,000,000 | 10,500,000 | 0 | |
Apr 01 2005 | CASI | CASI Pharmaceutica ... | CELGENE CORP /DE/ | 10% Owner | Buy | X | 1.50 | 7,000,000 | 10,500,000 | 23,750,000 | 16.8 M to 23.8 M (+41.79 %) |
Feb 18 2005 | CASI | CASI Pharmaceutica ... | Corrado Marc | V.P. Corporate Deve ... | Option Exercise | A | 3.70 | 100,000 | 370,000 | 100,000 | |
Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.68 | 500 | 1,840 | 49,500 | 49 K to 49.5 K (+1.02 %) |
Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.65 | 200 | 730 | 49,000 | 48.8 K to 49 K (+0.41 %) |
Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.63 | 3,107 | 11,278 | 48,800 | 45.7 K to 48.8 K (+6.80 %) |
Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.64 | 4,900 | 17,836 | 45,693 | 40.8 K to 45.7 K (+12.01 %) |
Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.67 | 1,993 | 7,314 | 40,793 | 38.8 K to 40.8 K (+5.14 %) |
Jan 12 2005 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 3.66 | 3,800 | 13,908 | 38,800 | 35 K to 38.8 K (+10.86 %) |
Dec 22 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Option Exercise | A | 3.02 | 100,000 | 302,000 | 100,000 | |
Dec 22 2004 | CASI | CASI Pharmaceutica ... | SAGLIO DANE R | Chief Financial Off ... | Option Exercise | A | 3.02 | 25,000 | 75,500 | 25,000 | |
Dec 22 2004 | CASI | CASI Pharmaceutica ... | Sidor Carolyn F | Corp. VP and Chief ... | Option Exercise | A | 3.02 | 25,000 | 75,500 | 25,000 | |
Dec 03 2004 | CASI | CASI Pharmaceutica ... | Sidor Carolyn F | Corp. VP and Chief ... | Option Exercise | A | 2.30 | 50,000 | 115,000 | 50,000 | |
Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.70 | 6,500 | 11,050 | 35,000 | 28.5 K to 35 K (+22.81 %) |
Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.69 | 2,600 | 4,394 | 28,500 | 25.9 K to 28.5 K (+10.04 %) |
Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.68 | 100 | 168 | 25,900 | 25.8 K to 25.9 K (+0.39 %) |
Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.67 | 400 | 668 | 25,800 | 25.4 K to 25.8 K (+1.57 %) |
Sep 27 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.66 | 400 | 664 | 25,400 | 25 K to 25.4 K (+1.60 %) |
Sep 07 2004 | CASI | CASI Pharmaceutica ... | KLEIN UDO | Senior Vice Preside ... | Buy | P | 1.49 | 1,800 | 2,682 | 1,800 | 0 to 1.8 K |
Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 2.00 | 4,200 | 8,400 | 25,000 | 20.8 K to 25 K (+20.19 %) |
Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.99 | 1,600 | 3,184 | 20,800 | 19.2 K to 20.8 K (+8.33 %) |
Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.97 | 900 | 1,773 | 19,200 | 18.3 K to 19.2 K (+4.92 %) |
Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.98 | 6,500 | 12,870 | 18,300 | 11.8 K to 18.3 K (+55.08 %) |
Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.95 | 6,100 | 11,895 | 11,800 | 5.7 K to 11.8 K (+107.02 %) |
Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.92 | 500 | 960 | 5,700 | 5.2 K to 5.7 K (+9.62 %) |
Jul 15 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Buy | P | 1.93 | 5,200 | 10,036 | 5,200 | 0 to 5.2 K |
Jul 15 2004 | CASI | CASI Pharmaceutica ... | SAGLIO DANE R | Chief Financial Off ... | Grant | A | 1.95 | 2,000 | 3,900 | 2,300 | 300 to 2.3 K (+666.67 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | BUSH DWIGHT L | Director | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | BUSH DWIGHT L | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | BUSH DWIGHT L | Director | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | BUSH DWIGHT L | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Option Exercise | A | 2.16 | 30,000 | 64,800 | 30,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | TARNOW MICHAEL M | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | CAPE RONALD | Director | Option Exercise | A | 2.16 | 30,000 | 64,800 | 30,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | CAPE RONALD | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | HUNTER CEVERA JENNIE | Director | Option Exercise | A | 2.16 | 30,000 | 64,800 | 30,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | HUNTER CEVERA JENNIE | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | RANDALL MARK C M | Director | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | RANDALL MARK C M | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | RANDALL MARK C M | Director | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | RANDALL MARK C M | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | BROOKS DONALD S | Director | Option Exercise | A | 2.16 | 30,000 | 64,800 | 30,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | BROOKS DONALD S | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | KNIGHT PETER S | Director | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | KNIGHT PETER S | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
Jun 17 2004 | CASI | CASI Pharmaceutica ... | Burns James S | President and CEO | Option Exercise | A | 2.14 | 500,000 | 1,070,000 | 500,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | KNIGHT PETER S | Director | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Jun 18 2004 | CASI | CASI Pharmaceutica ... | KNIGHT PETER S | Director | Grant | A | 2.16 | 11,574 | 25,000 | 16,127 | 4.6 K to 16.1 K (+254.21 %) |
May 07 2004 | CASI | CASI Pharmaceutica ... | SAGLIO DANE R | Chief Financial Off ... | Option Exercise | A | 2.68 | 50,000 | 134,000 | 50,000 | |
May 07 2004 | CASI | CASI Pharmaceutica ... | CAMPBELL NEIL J | President and COO | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 | |
May 07 2004 | CASI | CASI Pharmaceutica ... | CAMPBELL NEIL J | President and COO | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 |